On September 9, 2022 Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company reported that CEO, Dr James Garner, will be presenting at the upcoming 24th Annual Global Investment Conference, held in New York, NY, from 12 – 14 September 2022 (Press release, Kazia Therapeutics, SEP 9, 2022, https://www.prnewswire.com/news-releases/kazia-therapeutics-to-present-at-hc-wainwright-24th-annual-global-investment-conference-301620757.html [SID1234619337]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Dr Garner’s presentation will review three positive data read-outs that Kazia has reported so far in 2022 and will look ahead to some key developments that are anticipated over coming months.
Representatives of the Kazia management team will be available to conduct one-on-one meetings with institutional investors through the conference. To register for the conference, please visit: View Source